Tenon Medical, Inc. is a healthcare company focused on developing innovative solutions for the treatment of sacroiliac joint disorders
By leveraging advanced medical technology, the company aims to improve surgical outcomes and enhance patient recovery through its minimally invasive procedures and products. Tenon Medical is committed to addressing the unmet needs of patients suffering from chronic pain related to sacroiliac joint dysfunction by providing effective, safe, and durable treatment options, thus contributing to the ongoing advancement of orthopedic and pain management practices.
Tenon Medical shares are trading higher by 32% during Friday's session. The company announced that it has received three notices of allowance for its patent applications.
Tenon Medical shares are trading higher by 180% during Friday's session. The company announced the pricing of a $4.5 million public offering of 1.22 million shares and warrants.